CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML

NCT04787263 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Diffuse Large B Cell Lymphoma
Primary Mediastinal Lymphoma

Interventions

BIOLOGICAL: CD19-CAR_Lenti T cell

Sponsor

Bambino Gesù Hospital and Research Institute